title: [Which abortion prevention should be chosen in the case of antiphospholipid syndrome?].
authors.affiliation: Rheumaklinik Berlin-Buch, Berlin, Germany.
authors.forename: Erika
authors.initials: E
authors.lastname: Gromnica-Ihle
mesh_terms: D000022:Abortion, Spontaneous / Q000517:prevention & control*; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D016736:Antiphospholipid Syndrome / Q000150:complications*; D001241:Aspirin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005313:Fetal Death / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011247:Pregnancy
chemical_list: D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin